Abstract

Growing evidence suggests that the phenotype of endothelial cells during angiogenesis differs from that of quiescent endothelial cells, although little is known regarding the difference in the susceptibility to inflammation between both the conditions. Here, we assessed the inflammatory response in sparse and confluent endothelial cell monolayers. To obtain sparse and confluent monolayers, human umbilical vein endothelial cells were seeded at a density of 7.3×103 cells/cm2 and 29.2×103 cells/cm2, respectively, followed by culturing for 36 h and stimulation with tumor necrosis factor α. The levels of tumor necrosis factor α-induced E-selectin protein and mRNA expression were higher in the confluent monolayer than in the sparse monolayer. The phosphorylation of c-jun N-terminal kinase and p38 mitogen-activated protein kinase or nuclear factor-κB activation was not involved in this phenomenon. A chromatin immunoprecipitation assay of the E-selectin promoter using an anti-acetyl-histone H3 antibody showed that the E-selectin promoter was highly and specifically acetylated in the confluent monolayer after tumor necrosis factor α activation. Furthermore, chromatin accessibility real-time PCR showed that the chromatin accessibility at the E-selectin promoter was higher in the confluent monolayer than in the sparse monolayer. Our data suggest that the inflammatory response may change during blood vessel maturation via epigenetic mechanisms that affect the accessibility of chromatin.

Highlights

  • Vascular endothelial cells (ECs) play a pivotal role in the maintenance of the proper systemic vascular network [1,2,3]

  • Antibodies A monoclonal antibody against E-selectin was obtained from the American Type Culture Collection; anti-Eselectin (A-10: sc-137203) and anti-nuclear factor-kB (NF-kB) p65 (C-20: sc-372) antibodies were obtained from Santa Cruz Biotechnology; antiphospho-NF-kB p65 Ser 536 (#3031), anti-SAPK/jun N-terminal kinase (JNK) (#9252), anti-p38 mitogen-activated protein kinase (MAPK) (#9212), anti-phospho-SAPK/JNK (#9251), and anti-phospho-p38 MAPK (#4511) antibodies were obtained from Cell Signaling Technology; anti-lamin A/C (SAB4200236) and anti-actin (A5060) antibodies were obtained from SigmaAldrich; an anti-a-tubulin antibody (PM054-7) was obtained from Medical & Biological Laboratories; an anti-acetyl-histone H3 antibody (06-599) was obtained from Millipore; an Alexa Fluor 488-conjugated goat anti-mouse IgG antibody (A11017) was obtained from Life Technologies; horseradish peroxidase (HRP)linked anti-mouse (NA931V) and anti-rabbit (NA9340V) secondary antibodies were obtained from GE Healthcare

  • We found that tumor necrosis factor a (TNFa)-induced E-selectin expression levels in the Human umbilical vein endothelial cells (HUVECs) was higher in the confluent monolayer than in the sparse monolayer, whereas the expression levels of actin were comparable in HUVECs cultured under these two conditions (Figure 1B)

Read more

Summary

Introduction

Vascular endothelial cells (ECs) play a pivotal role in the maintenance of the proper systemic vascular network [1,2,3]. At the site of inflammation, leukocytes interact with activated ECs via adhesion molecules, resulting in rolling, adhesion, and transmigration [6]. These processes are intimately involved in pathogenesis of inflammatory diseases [7,8], as well as resolution of inflammation [9,10]. It is known that sparse and confluent endothelial cells show different phenotypes including cell growth, apoptosis, and cytoskeleton rearrangement. Effect of cell density on endothelial gene regulation is partly understood

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call